Circulating levels of urocortin neuropeptides are impaired in children with overweight. Issue 2 (27th January 2022)

• Record Type: Journal Article
• Authors: Kavalakatt, Sina; Khadir, Abdelkrim; Madhu, Dhanya; Devarajan, Sriraman; Warsame, Samia; AlKandari, Hessa; AlMahdi, Maria; Koistinen, Heikki A.; Al‐Mulla, Fahd; Tuomilehto, Jaakko; Abubaker, Jehad; Tiss, Ali
• Is Part Of: Obesity. Volume 30:Issue 2(2022)
• Page Start: 472
• Page End: 481
• Publication Date: 2022-01-27
• Subjects: Obesity -- Periodicals; 616.398005
• DOI: 10.1002/oby.23356
• Languages: English
• ISSNs: 1930-7381

Abstract

Abstract: Objective: The corticotropin‐releasing factor neuropeptides (corticotropin‐releasing hormone [CRH] and urocortin [UCN]‐1, 2, 3) and spexin contribute to the regulation of energy balance and inhibit food intake in mammals. However, the status of these neuropeptides in children with overweight has yet to be elucidated. This study investigated the effect of increased body weight on the circulating levels of these neuropeptides. Methods: A total of 120 children with a mean age of 12 years were enrolled in the study. Blood samples were collected to assess the circulating levels of neuropeptides and were correlated with various anthropometric, clinical, and metabolic markers. Results: Plasma levels of UCNs were altered in children with overweight but less so in those with obesity. Furthermore, the expression pattern of UCN1 was opposite to that of UCN2 and UCN3, which suggests a compensatory effect. However, no significant effect of overweight and obesity was observed on CRH and spexin levels. Finally, UCN3 independently associated with circulating zinc‐alpha‐2‐glycoprotein and UCN2 levels, whereas UCN1 was strongly predicted by TNFα levels. Conclusions: Significant changes in neuropeptide levels were primarily observed in children with overweight and were attenuated with increased obesity. This suggests the presence of a compensatory mechanism for neuropeptides to curb the progression of obesity.